Praxis Precision Medicines, Inc. (PRAX) stock analysis

In our weekly check, Praxis Precision Medicines, Inc. is graded F (A to F). Of 18 checks on debt, profit, cash flow and trend: 5 pass, warnings: 4, red flags: 9.

About Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as PRAX.

What our checks show for PRAX

Red flags

Warning signs

Strengths

Similar companies

KRYS · TGTX · PTGX · SYRE · MDGL · PCVX

Questions

What grade does Praxis Precision Medicines, Inc. (PRAX) have?

In our weekly check, Praxis Precision Medicines, Inc. is graded F (A to F). Of 18 checks on debt, profit, cash flow and trend: 5 pass, warnings: 4, red flags: 9. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of PRAX stock?

This week's biggest flags for Praxis Precision Medicines, Inc.: Weak EPS growth, Thin margins, Weak free cash flow. In total 13 of 18 checks show a warning or a red flag.

What does Praxis Precision Medicines, Inc. do?

Praxis Precision Medicines, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as PRAX.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis